A. M. Demina,
A. G. Pershina*bc,
K. V. Nevskayab,
L. V. Efimovab,
N. N. Shchegolevad,
M. A. Uimind,
D. K. Kuznetsove,
V. Ya. Shure,
V. P. Krasnova and
L. M. Ogorodovab
aPostovsky Institute of Organic Synthesis of RAS, Ural Branch, Yekaterinburg, Russia
bSiberian State Medical University, Tomsk, Russia. E-mail: allysyz@mail.ru; Fax: +7 382 2533309; Tel: +7 382 2901101 ext. 1634
cRussian National Research Tomsk Polytechnic University, Tomsk, Russia
dMikheev Institute of Metal Physics of RAS, Ural Branch, Yekaterinburg, Russia
eUral Centre for Shared Use “Modern Nanotechnology”, Institute of Natural Sciences, Ural Federal University, Yekaterinburg, Russia
First published on 5th September 2016
Correction for ‘pHLIP-modified magnetic nanoparticles for targeting acidic diseased tissue’ by A. M. Demin et al., RSC Adv., 2016, 6, 60196–60199.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2016 |